This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Oncology  • Head & Neck Cancer  • Neoplasms of Head & Neck  • Pathology of Head & Neck  • Salivary Gland Disorders  • Diagnosis  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Otolaryngol Head Neck Surg. 2006;132:556.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Diagnosis: Epithelial-myoepithelial carcinoma (EMC)

Epithelial-myoepithelial carcinoma, a rare malignant tumor of the salivary glands, was first described in 1972¹ and was established as a distinct diagnostic entity by the World Health Organization in 1991.² Before its metastatic potential was realized in studies with sufficient long-term follow-up, EMC was reported under a variety of names, including glycogen-rich adenoma, clear cell adenoma, adenomyoepithelioma, tubular solid adenoma, and salivary duct carcinoma.³ Furthermore, it is difficult to assess the incidence of EMC because it was not included as a specific entity until recently. Current evaluations demonstrate that EMC represents approximately 1% of all salivary gland neoplasms, occurs predominantly in the parotid gland (70%-80%), has a predilection for females, and has a peak incidence in the seventh and eighth decades of life (mean age at onset, 60 years).^2-5 However, the youngest patient in the case files of the Armed Forces Institute of Pathology is 15 years old, and EMC . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Pathology Quiz Case 1
Shane Zim, Jennifer Lee, and Deborah Schofield
Arch Otolaryngol Head Neck Surg. 2006;132(5):554.
EXTRACT | FULL TEXT